Aesica Pharmaceuticals

Aesica is a pioneering and customer focussed supplier of Active Pharmaceutical Ingredients (APIs), finished dosage forms and custom synthesis development solutions for pharmaceutical and biotechnological applications.

Aesica offers the complete product development service from early phase clinical trials through to scale-up and multi-tonne commercial manufacturing. All projects are supported by analytical, regulatory, supply chain services, and are handled by Aesica’s experienced project management team.

Aesica's API development facilities include custom-built process development laboratories, kilo lab and a pilot plant for early phase product development. Aesica's API commercial production facilities feature advanced multi-product processing systems including capabilities for the manufacture of potent drugs. The company's formulation facilities offer an array of technologies for the manufacture and packaging of finished pharmaceutical products including liquid and solid dosage forms, anaesthetics and active drugs.

Aesica is experienced in managing technical transfers with flexibility and speed and has clear procedures to ensure all projects are carried out with maximum efficiency.

With 95 percent of its business based outside of the United Kingdom, Aesica supplies products and services to the world’s major pharmaceutical markets including Europe, Japan and North America.

API Manufacturing Facilities

Aesica’s commercial API manufacturing facilities comprise of seven multi-product plants several of which are equipped with potency facilities. Aesica has experience in handling technical transfer projects with maximum efficiency and speed. Over the years the company established itself as a reliable supplier of bulk APIs and has become a partner of choice for several of the top-ten world’s leading pharmaceutical companies and generic manufacturers.

API Development Services

Aesica provides API development services and custom synthesis solutions giving its clients unrivalled responsiveness and adaptability as well as total confidence in the quality of service. The company develops and manufactures a broad range of chemical synthetic compounds for use in phase one to three clinical trials including potent chemicals. All projects are supported by Aesica’s experienced project management team.

• Process development
• Scale-up / kilo lab / pilot plant
• cGMP manufacturing
• Analytical development and regulatory support

Liquid / Solid Dosage Form Manufacturing

Aesica offers a broad selection of process technologies for the manufacture and packaging of pharmaceutical products, which includes:

• Liquid and solid dosage form manufacturing
• Active drugs
• Anaesthetics
• Packaging provided in bottles, blister packs and sachets

Aesica provides regulatory, analytical and supply chain services to support all projects. Aesica has clear technical transfer procedures to ensure all product introductions and launches are carried out smoothly and with maximum efficiency. The company supplies products to over 30 countries worldwide and has experience of managing process changes with flexibility and speed.

cGMP Manufacturing / MHRA and FDA Audits

Aesica strives to provide the highest quality products and services. The company’s compliance with the international regulatory standards and requirements has always been the most important part of its business.

All Aesica’s manufacturing sites are approved by MHRA authorities and comply with cGMP manufacturing standards and requirements. All company’s API facilities are inspected and approved by FDA. During all audits Aesica demonstrated that its regulatory standards are amongst the highest in the pharmaceutical industry.

Aesica also meets the requirements of ISO 9001-2000 international standard, which promotes the approach to provide world-class service and exceed customers’ expectations.